Hancock Whitney’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
16,896
+5,887
| +53% | +$411K | 0.02% | 387 |
|
|
2025
Q1 | $809K | Buy |
11,009
+262
| +2% | +$19.3K | 0.03% | 350 |
|
|
2024
Q4 | $704K | Buy |
10,747
+97
| +0.9% | +$6.36K | 0.02% | 369 |
|
|
2024
Q3 | $830K | Sell |
10,650
-151
| -1% | -$11.8K | 0.03% | 345 |
|
|
2024
Q2 | $842K | Buy |
10,801
+1,553
| +17% | +$121K | 0.03% | 334 |
|
|
2024
Q1 | $627K | Sell |
9,248
-386
| -4% | -$26.2K | 0.02% | 382 |
|
|
2023
Q4 | $649K | Buy |
9,634
+747
| +8% | +$50.3K | 0.02% | 391 |
|
|
2023
Q3 | $602K | Sell |
8,887
-465
| -5% | -$31.5K | 0.02% | 382 |
|
|
2023
Q2 | $669K | Buy |
9,352
+1,001
| +12% | +$71.6K | 0.03% | 379 |
|
|
2023
Q1 | $579K | Sell |
8,351
-561
| -6% | -$38.9K | 0.02% | 402 |
|
|
2022
Q4 | $604K | Buy |
8,912
+735
| +9% | +$49.8K | 0.02% | 390 |
|
|
2022
Q3 | $449K | Buy |
8,177
+1,227
| +18% | +$67.4K | 0.02% | 433 |
|
|
2022
Q2 | $459K | Buy |
6,950
+67
| +1% | +$4.43K | 0.02% | 439 |
|
|
2022
Q1 | $457K | Sell |
6,883
-489
| -7% | -$32.5K | 0.02% | 488 |
|
|
2021
Q4 | $429K | Buy |
7,372
+879
| +14% | +$51.2K | 0.01% | 510 |
|
|
2021
Q3 | $390K | Buy |
6,493
+465
| +8% | +$27.9K | 0.01% | 526 |
|
|
2021
Q2 | $361K | Buy |
+6,028
| New | +$361K | 0.01% | 637 |
|